SGP
SpyGlass Pharma, Inc.
NASDAQ: SGP · HEALTHCARE · BIOTECHNOLOGY
$22.94
+3.66% today
Updated 2026-04-30
Market cap
$786.19M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.25
Dividend yield
—
52W range
$20 – $32
Volume
0.1M
SpyGlass Pharma, Inc. (SGP) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 1
Last 1 quarters
Avg EPS surprise
+21.5%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-7.3%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-7.3%
2026-03-27
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-27 | $-0.38 | +21.5% | $25.20 | $23.37 | -7.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.48 | $-0.38 | +21.5% | — | — |
Frequently asked questions
Has SpyGlass Pharma, Inc. beaten earnings estimates?
SpyGlass Pharma, Inc. has beaten Wall Street EPS estimates in 1 of its last 1 quarterly reports, with an average EPS surprise of +21.5% over the last 1 quarters.
How does SGP stock react to earnings?
SGP stock has moved an average of -7.3% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.